Rockefeller Capital Management L.P. Bristol Myers Squibb CO Transaction History

Rockefeller Capital Management L.P.

$36.3 Billion
Q3 2024

A detailed history of Rockefeller Capital Management L.P. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 916,240 shares of BMY stock, worth $52.9 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

916,240

Previous 927,025 1.16%

Holding current value

$52.9 Million

Previous $38.5 Million 23.16%

% of portfolio

0.13%

Previous 0.11%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $427,733 - $558,123	-10,785 Reduced 1.16%	916,240 $47.4 Million
Q2 2024 Aug 12, 2024	BUY	$40.25 - $52.99 $3.63 Million - $4.77 Million	90,101 Added 10.77%	927,025 $38.5 Million
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $11.8 Million - $13.3 Million	244,951 Added 41.38%	836,924 $45.4 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $9.63 Million - $11.5 Million	-198,652 Reduced 25.13%	591,973 $30.4 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $9.09 Million - $10.2 Million	-157,003 Reduced 16.57%	790,625 $45.9 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $2.31 Million - $2.57 Million	36,294 Added 3.98%	947,628 $60.6 Million
Q1 2023 May 17, 2023	BUY	$65.71 - $74.53 $12.3 Million - $14 Million	187,528 Added 25.91%	911,334 $63.2 Million
Q4 2022 Mar 06, 2023	SELL	$68.48 - $81.09 $1.73 Million - $2.05 Million	-25,228 Reduced 3.37%	723,806 $52.1 Million
Q3 2022 Nov 02, 2022	BUY	$0.13 - $76.84 $12,991 - $7.68 Million	99,931 Added 15.4%	749,034 $53.2 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $4.48 Million - $4.94 Million	-61,714 Reduced 8.68%	649,103 $50 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $1.03 Million - $1.24 Million	16,774 Added 2.42%	710,817 $51.9 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $10.7 Million - $12.5 Million	-199,316 Reduced 22.31%	694,043 $43.3 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $3.31 Million - $3.88 Million	56,007 Added 6.69%	893,359 $52.9 Million
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $14.5 Million - $15.8 Million	234,152 Added 38.82%	837,352 $56 Million
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $2.58 Million - $2.9 Million	43,468 Added 7.77%	603,200 $38.1 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $2.68 Million - $3.04 Million	46,468 Added 9.05%	559,732 $34.7 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $3.25 Million - $3.6 Million	56,597 Added 12.39%	513,264 $30.9 Million
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $293,561 - $343,201	5,355 Added 1.19%	456,667 $26.9 Million
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $9.48 Million - $13.8 Million	204,413 Added 82.79%	451,312 $25.2 Million
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $2.9 Million - $3.79 Million	58,990 Added 31.39%	246,899 $15.9 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $3.77 Million - $4.47 Million	88,067 Added 88.21%	187,909 $9.53 Million
Q2 2019 Aug 09, 2019	SELL	$44.62 - $49.34 $4.81 Million - $5.32 Million	-107,736 Reduced 51.9%	99,842 $4.53 Million
Q1 2019 May 10, 2019	BUY	$45.12 - $53.8 $466,405 - $556,130	10,337 Added 5.24%	207,578 $9.9 Million
Q4 2018 Feb 12, 2019	BUY	$48.76 - $63.23 $2.87 Million - $3.72 Million	58,786 Added 42.46%	197,241 $10.3 Million
Q3 2018 Nov 02, 2018	SELL	$55.19 - $62.25 $367,013 - $413,962	-6,650 Reduced 4.58%	138,455 $8.6 Million
Q2 2018 Jul 31, 2018	SELL	$50.53 - $62.98 $10.2 Million - $12.8 Million	-202,521 Reduced 58.26%	145,105 $8.03 Million
Q1 2018 May 09, 2018	BUY	$59.92 - $68.98 $20.8 Million - $24 Million	347,626 New	347,626 $22 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Account

Rockefeller Capital Management L.P. Bristol Myers Squibb CO Transaction History